Menu:
Alzheimer's | Cardiopulmonary | Chronic Pain | Dermatitis | Diabetes | Epilepsy | Fibromyalgia | Gastric Disorders | Geriatrics | Glaucoma | Headaches | Hypertension | Macular Degeneration | Managed Care | Multiple Sclerosis | Neonatology | Nephrology | Neuroscience | Oncology | Pediatrics | Psychiatric | Rheumatism | Sleep Disorders | Spasticity | Stroke | Womens Health
Purchase our video content securely online with PayPal:
Psychiatry Educational Programming
Management of Anorexia & Bulemia
Program no. MB-1007M, 60 minutes
Presenters: Mary E. Muscari, PhD, CRNP, CS; Marrian Farrell, PhD, RNC, CS
Describes clinical manifestations and potential complications associated with anorexia and bulimia nervosa; discuss nursing techniques used to prevent and manage the physiologic consequences; develop an understanding of the psychosocial needs of clients with eating disorders; and select psychosocial interventions based on appropriate theoretical perspectives for clients with eating disorders.
Psychiatry Update: Panic Disorder
Program no. MD-0313P, 60 minutes
Presenters: S.A. Saeed, MD; William C. Sanderson, PhD
Treatment of Panic Disorder and Diagnosis of Panic Disorder.
Advances in Managing & Treating Attention Deficit Disorder
Program no. MD-0422P, 60 minutes
Presenters: Joseph P. Horrigan, MD; L. Jarrett Barnhill, Jr., MD; William Lord Coleman, MD
Attention Deficit Hyperactivity Disorder Throughout the Life Cycle; Psychiatric Comorbidity; The Impact of Attention Deficit on Learning.
Advances in Treating Social Phobia
Program no.MD-1030M , 60 minutes
Presenters: Atezaz Saeed, MD; Timothy Bruce, PhD
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the disorders which tend to be commonly comorbid with social phobia; understand indications for drug therapy, cognitive behavior therapy, and combined treatment for social phobia; Describe classes of drugs most appropriate in treatment and first line treatments and follow-up treatment in case of non-response.
A Closer Look at the Diagnosis & Treatment of Schizophrenia
Program no. MD-0918P, 60 minutes
Presenters: Mark D. Watanabe, PharmD, PhD; S. Charles Schulz, MD; Peter F. Buckley, MD
Define the demographic characteristics of schizophrenia; Appreciate the core diagnostic features of schizophrenia; Discuss which conditions mimic the presentation of schizophrenia; Understand the role of ancillary tests and other information in differentiating schizophrenia from neurological conditions; Identify new drugs available for full syndrome of schizophrenia; Distinguish the difference between the effects of traditional drugs and new drugs; Describe the current theories proposed for the pathogenesis of schizophrenia and their implications for rational drug therapy.
Stress Management for Nurses
Program no. MD-0408M, 30 minutes
Presenters: Donna Poole, RN, MSN, CS
This program will train the nurse in some of the latest techniques to mitigate or alleviate stress induced by the caregiver's workplace. Several options are highlighted that can be implemented in the workplace to reduce the impact of stress causing events.
Detecting Depression and Nursing Strategies
Program no. MA-1018N, 120 minutes
Presenters: Gail Stuart, PhD, RN, CS, FAAN; Michele Laria, MSN, RN; Linda Beeber, PhD, RN; Carol Glod, MS, RN
Prominent physicians and nurses discuss the fundamentals of depression and its detection as well as treatment options for the disease. Specific topics include: definition, epidemiology, consequences and diagnosis of depression/patient education and compliance counseling; etiology of depression; treatment options - psychotherapy; treatment options - medications.
Postpartum Mood Disorders
Program no. MD-0715N, 60 minutes
Presenters: Laura Miller, MD; Katherine L. Wisner, MD; Susan Baab, RN, MSN, CS
Understand the clinical features of ostpartum "blues", depression and psychoses. Understand the differences in clinical presentation and correlates, etiology and course of illness for the three categories of postpartum disorders; Identify medications which are reasonable choices for women with postpartum depression; Develop a monitoring plan for babies whose mothers take antidepressants and breastfeed; Learn the precautions of treating them under those circumstances; Gain an understanding of the best treatment options for postpartum bipolar women, including breastfeeding mothers, after a careful cost-risk analysis.
Pharmacy Update: Advances in Determining & Treating Schizophrenia
Program no. MD-0415P, 90 minutes
Presenters: Mark Watanabe, PharmD; Barbara Poddig, PharmD, BCPP; LaGenia Bailey, PharmD; Mark E. Schneiderhan, PharmD, BCPP
Describe the therapeutic goals of using typical antipsychotic agents; Understand the common side effects of typical antipsychotic agents; Identify characteristics of "High potency" vs "Low potency" antipsychotic agents.
Bipolar Disorder: Current Concepts in Diagnosis & Treatment
Program no. ME-0324N, 90 minutes
Presenters: Recognize and diagnose bipolar disorder using DSM-IV criteria; Address important diagnostic considerations in classifying bipolar disorder; Identify the disorders which tend to be commonly comorbid bipolar disorder; Describe the classes of drugs most appropriate for treatment and factors in choosing an appropriate first line treatment and follow-up treatments in case of non-response.
Advances in the Treatment of Depression
Program no. MD-0715N, 120 minutes
Presenters: Phebe Tucker, MD; Lawrence J. Cohen, PharmD, FASHP; Charles B. Nemeroff, MD, PhD; Charles F. Reynolds III, MD; Kevin Scott Ferentz, MD.
Explains short and long term treatment in the elderly, describes clinical drug therapy or treatment protocols, reviews disease management of depression in the managed care setting, discusses pharmacoeconomics of depression and explains the contemporary management of depression.
Managing Depression: Considerations in the Older Patient
Program no. MC-0515M, 90 minutes
Presenters: Robert L. Spitzer, MD; K. Ranga Krishnan, MD; Sheldon H. Preskorn, MD
This program features leading medical experts presenting information on short and long term treatment of mood disorders. The faculty will address diagnosis, treatment options, clinical drug therapy, and management of mood disorders in the older patient. Additional topics wil be: polypharmacy, comorbid medical conditions, drug interactions, and the impact of depression on cognition, functions, and motor skills.
Challenges in Depression: Managing the Patient with Special Needs
Program no. MB-1115M, 120 minutes
Presenters: James H. Kocsis, MD; Sanford Finkel, MD; Paul J. Goodnick, MD; Andrew Winokur, MD, PhD; Susan G. Kornstein, MD
Review developments in the diagnosis of patients with depressive disorders; Review approaches to treatment; Review current status of preventing relapse; Review and focus on the needs of special populations with depression.
Management of Panic & Anxiety Disorders
Program no. MC-0227M, 90 minutes
Presenters: David Katerndahl, MD; Laszlo Papp, MD; Eric Hollander, MD; Dennis Charney, MD and Panelist, Martha J. Haun, MD
Care-Seeking Behavior in Panic Disorder & Physician Recognition, Panic Disorders, Obsessive-Compulsive and Related Disorders, Post-Traumatic Stress Disorder and Generalized Disorders.
Managing Depression: Mood Disorders Across the Reproductive Cycle
Program no. MC-0424M, 90 minutes
Presenters: Steven F. Pariser, MD; Kimberly A. Yonkers, MD; Susan Kornstein, MD; Anthony Rothschild, MD; Lee Cohen, MD; Zachary N. Stowe, MD
Premenstrual Dysphoric Disorder; Treatment Options for the Female Patient; Menopause, Peri-Menopause, and Depression; Depression in Pregnancy and the Postpartum State.
Diagnosis & Treatment of Obsessive-Compulsive Disorder: An Evidence-based Approach
Program no. ME-0115M, 60 minutes
Presenters: Sy Atezaz Saeed, MD; Donald W. Black, MD; Sandra Hable, RN, EdM; Timothy Bruce, PhD
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the behavior therapy and combined treatment for obsessive-compulsive disorder; Describe the classes of drugs most appropriate in the treatment of this disorder and factors in determining the appropriate first line treatment and followup in case of non-response.
Postpartum Mood Disorders
Program no. MD-0715N, 60 minutes
Presenters: Laura Miller, MD; Katherine L. Wisner, MD; Susan Baab, RN, MSN, CS
Understand the clinical features of ostpartum "blues", depression and psychoses. Understand the differences in clinical presentation and correlates, etiology and course of illness for the three categories of postpartum disorders; Identify medications which are reasonable choices for women with postpartum depression; Develop a monitoring plan for babies whose mothers take antidepressants and breastfeed; Learn the precautions of treating them under those circumstances; Gain an understanding of the best treatment options for postpartum bipolar women, including breastfeeding mothers, after a careful cost-risk analysis.
MEDIVISION ™ does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professionals.